دورية أكاديمية
RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity.
| العنوان: | RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity. |
|---|---|
| المؤلفون: | Maroofian, Reza, Sarraf, Payam, O'Brien, Thomas J, Kamel, Mona, Cakar, Arman, Elkhateeb, Nour, Lau, Tracy, Patil, Siddaramappa Jagdish, Record, Christopher J, Horga, Alejandro, Essid, Miriam, Selim, Laila, Benrhouma, Hanene, Younes, Thouraya Ben, Zifarelli, Giovanni, Pagnamenta, Alistair T, Bauer, Peter, Khundadze, Mukhran, Mirecki, Andrea, Kamel, Sara Mahmoud |
| المصدر: | Brain: A Journal of Neurology; Jul2024, Vol. 147 Issue 7, p2334-2343, 10p |
| مصطلحات موضوعية: | MOTOR neuron diseases, NERVE conduction studies, SPASTICITY, SPASTIC paralysis, FAMILIAL spastic paraplegia, DISEASE duration, SARCOPLASMIC reticulum |
| مستخلص: | Heterozygous RTN2 variants have been previously identified in a limited cohort of families affected by autosomal dominant spastic paraplegia (SPG12-OMIM:604805) with a variable age of onset. Nevertheless, the definitive validity of SPG12 remains to be confidently confirmed due to the scarcity of supporting evidence. In this study, we identified and validated seven novel or ultra-rare homozygous loss-of-function RTN2 variants in 14 individuals from seven consanguineous families with distal hereditary motor neuropathy (dHMN) using exome, genome and Sanger sequencing coupled with deep-phenotyping. All affected individuals (seven males and seven females, aged 9–50 years) exhibited weakness in the distal upper and lower limbs, lower limb spasticity and hyperreflexia, with onset in the first decade of life. Nerve conduction studies revealed axonal motor neuropathy with neurogenic changes in the electromyography. Despite a slowly progressive disease course, all patients remained ambulatory over a mean disease duration of 19.71 ± 13.70 years. Characterization of Caenorhabditis elegans RTN2 homologous loss-of-function variants demonstrated morphological and behavioural differences compared with the parental strain. Treatment of the mutant with an endoplasmic/sarcoplasmic reticulum Ca2+ reuptake inhibitor (2,5-di-tert-butylhydroquinone) rescued key phenotypic differences, suggesting a potential therapeutic benefit for RTN2-disorder. Despite RTN2 being an endoplasmic reticulum (ER)-resident membrane shaping protein, our analysis of patient fibroblast cells did not find significant alterations in ER structure or the response to ER stress. Our findings delineate a distinct form of autosomal recessive dHMN with pyramidal features associated with RTN2 deficiency. This phenotype shares similarities with SIGMAR1-related dHMN and Silver-like syndromes, providing valuable insights into the clinical spectrum and potential therapeutic strategies for RTN2-related dHMN. [ABSTRACT FROM AUTHOR] |
| Copyright of Brain: A Journal of Neurology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| قاعدة البيانات: | Complementary Index |
Full Text Finder كن أول من يترك تعليقا!